Researchers demonstrated how tropisetron, at a dose of 3 mg/kg for two weeks, attenuated renal fibrosis by regulating TGF-β1, p53, and the expression of extracellular matrix metalloproteinases. Here, TP53 is linked to renal fibrosis.